Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche
- PMID: 25231870
- PMCID: PMC4185210
- DOI: 10.1038/nature13545
Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche
Abstract
Age at menarche is a marker of timing of puberty in females. It varies widely between individuals, is a heritable trait and is associated with risks for obesity, type 2 diabetes, cardiovascular disease, breast cancer and all-cause mortality. Studies of rare human disorders of puberty and animal models point to a complex hypothalamic-pituitary-hormonal regulation, but the mechanisms that determine pubertal timing and underlie its links to disease risk remain unclear. Here, using genome-wide and custom-genotyping arrays in up to 182,416 women of European descent from 57 studies, we found robust evidence (P < 5 × 10(-8)) for 123 signals at 106 genomic loci associated with age at menarche. Many loci were associated with other pubertal traits in both sexes, and there was substantial overlap with genes implicated in body mass index and various diseases, including rare disorders of puberty. Menarche signals were enriched in imprinted regions, with three loci (DLK1-WDR25, MKRN3-MAGEL2 and KCNK9) demonstrating parent-of-origin-specific associations concordant with known parental expression patterns. Pathway analyses implicated nuclear hormone receptors, particularly retinoic acid and γ-aminobutyric acid-B2 receptor signalling, among novel mechanisms that regulate pubertal timing in humans. Our findings suggest a genetic architecture involving at least hundreds of common variants in the coordinated timing of the pubertal transition.
Figures
References
-
- Prentice P, Viner RM. Pubertal timing and adult obesity and cardiometabolic risk in women and men: a systematic review and meta-analysis. Int. J. Obes. (Lond) 2013;37:1036–43. - PubMed
-
- Silveira LFG, Latronico AC. Approach to the patient with hypogonadotropic hypogonadism. J. Clin. Endocrinol. Metab. 2013;98:1781–8. - PubMed
Additional references cited in the Methods
MeSH terms
Substances
Grants and funding
- R01 NS017950/NS/NINDS NIH HHS/United States
- MC_UU_12013/3/MRC_/Medical Research Council/United Kingdom
- 16565/CRUK_/Cancer Research UK/United Kingdom
- 11022/CRUK_/Cancer Research UK/United Kingdom
- MC_UU_12015/1/MRC_/Medical Research Council/United Kingdom
- MC_U106179471/MRC_/Medical Research Council/United Kingdom
- MC_U106179472/MRC_/Medical Research Council/United Kingdom
- 16563/CRUK_/Cancer Research UK/United Kingdom
- 10119/CRUK_/Cancer Research UK/United Kingdom
- 098381/WT_/Wellcome Trust/United Kingdom
- 10118/CRUK_/Cancer Research UK/United Kingdom
- G1000143/MRC_/Medical Research Council/United Kingdom
- MR/J012165/1/MRC_/Medical Research Council/United Kingdom
- R01 AG041517/AG/NIA NIH HHS/United States
- UL1 TR001108/TR/NCATS NIH HHS/United States
- 102215/WT_/Wellcome Trust/United Kingdom
- MC_UU_12015/2/MRC_/Medical Research Council/United Kingdom
- MC_PC_15018/MRC_/Medical Research Council/United Kingdom
- P50 CA116201/CA/NCI NIH HHS/United States
- G0401527/MRC_/Medical Research Council/United Kingdom
- MC_UU_12013/1/MRC_/Medical Research Council/United Kingdom
- G0701863/MRC_/Medical Research Council/United Kingdom
- 10124/CRUK_/Cancer Research UK/United Kingdom
- U01 AG049505/AG/NIA NIH HHS/United States
- 16561/CRUK_/Cancer Research UK/United Kingdom
- G9815508/MRC_/Medical Research Council/United Kingdom
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous
